17.01.2014 Views

Invasive breast carcinoma - IARC

Invasive breast carcinoma - IARC

Invasive breast carcinoma - IARC

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Fig. 1.27 Medullary <strong>carcinoma</strong>. The tumour is composed of a syncytial sheet of large pleomorphic cells. There<br />

is no glandular differentiation. The adjacent stroma contains numerous plasma cells and mature lymphocytes.<br />

been reported {1386,3170}. MC typically<br />

lack estrogen receptors (ER) expression<br />

{1244,1340,2204,2272}, and have a low<br />

incidence of ERBB2 overe x p re s s i o n<br />

{2439,2746,2750}.<br />

The cytokeratin profile is similar in typical<br />

and atypical MC, and does not differ significantly<br />

from that of common ductal<br />

tumours {610,1340,2943}. The cell cohesiveness<br />

of MC, contrasting with the<br />

poorly diff e rentiated pattern and high<br />

mitotic index, has been characterized by<br />

the expression of the intercellular adhesion<br />

molecule-1 {156} and of E-cadherin<br />

{444}. This feature might account for the<br />

good limitation of the tumour and the late<br />

axillary lymph node extension.<br />

Immunophenotyping of the lymphoid<br />

infiltrate of MC has shown that most cells<br />

correspond to mature T lymphocytes, a<br />

profile similar to that observed in common<br />

ductal <strong>carcinoma</strong>s {214}. Evidence<br />

Fig. 1.28 Medullary <strong>carcinoma</strong>. Note multinucleated<br />

malignant cells with atypical mitoses.<br />

of polyclonality of the B-cell infiltrate has<br />

been obtained {1510}. Plasma cells<br />

w e re found to express IgG {1310} or<br />

IgA {1254}. The recent finding of an<br />

i n c reased number of activated cytotoxic<br />

lymphocytes in MC may correspond to<br />

an active host versus tumour response<br />

{3169}. Expression of HLA class I and<br />

class II molecules by <strong>carcinoma</strong> cells,<br />

as a cause or a consequence of the<br />

immune response, was reported to characterize<br />

MC {840}. Although EBV-associated<br />

lymphoepithelioma shares some<br />

morphological features with MC, only a<br />

few cases were found associated with<br />

EBV, in contrast with the 31-51% rate of<br />

EBV-positive common ductal <strong>carcinoma</strong>s<br />

{310,857}.<br />

Genetics<br />

A high frequency of MC has been reported<br />

in patients with BRCA1 germ line<br />

mutation, whereas this observation was<br />

less common among patients with<br />

BRCA2 mutation or with no known germ<br />

line mutation. Typical MC were observed<br />

in 7.8% {1767} to 13% {8} of BRCA1-<br />

associated <strong>carcinoma</strong>s, versus 2% in<br />

control populations. However, the presence<br />

of medullary features was found in<br />

35% {1767} to 60% {121} of tumours arising<br />

in BRCA1 carriers. Reciprocally, in a<br />

population of MC, germ line mutations of<br />

BRCA1 was observed in 11% of the<br />

cases {764}. There is thus a large overlap<br />

between medullary features and the phenotype<br />

of BRCA1 germline associated<br />

tumours, but not all BRCA1 mutations<br />

lead to medullary phenotype.<br />

MC are also characterized by a high rate<br />

of TP53 alterations. Somatic mutations<br />

were found in 39% {1766} to 100% {643}<br />

of MC, together with protein accumulation<br />

in 61-87% of the cases {643,<br />

711,1345}. This contrasts with the 25-<br />

30% rate of TP53 alterations found in<br />

common ductal <strong>carcinoma</strong>s {643,711,<br />

1345}. No specific TP53 mutation was<br />

found to characterize MC {643} but TP53<br />

overstaining may be considered as a<br />

biological marker of MC. Both TP53 and<br />

BRCA1 are involved in the process of<br />

DNA repair and the alteration of these<br />

genes, together with a high proliferation<br />

rate, may account for the high sensitivity<br />

of MC to radio- and/or chemotherapy.<br />

Prognosis and predictive factors<br />

MC has been re p o rted to have a better<br />

p rognosis than the common IDC {1339,<br />

1 7 4 0 , 1 9 0 8 , 2 2 0 4 , 2 3 3 4 , 2 3 5 2 , 2 3 6 7 , 2 3 7 0 ,<br />

3064} but this has been questioned by<br />

others {285,771,876}. The overall 10-yearsurvival<br />

re p o rted for MC varies between<br />

about 50% {285,771,1740} to more than<br />

90% {1339,2334,3064}. Diff e rences in<br />

diagnostic criteria may account for this<br />

disparity and several re p o rts underline<br />

that stringency in diagnostic criteria is<br />

re q u i red to preserve the anatomo-clinical<br />

identity of MC {876,2334,2370,3064}<br />

which is justified by the characteristic<br />

p rognosis of this tumour. The outcome of<br />

MC associated with more than thre e<br />

metastatic axillary lymph nodes has been<br />

re p o rted to be poor {285,1740,2202} or<br />

no diff e rent from that of common ductal<br />

tumours {876,2352}. However, less than<br />

10% of MC {876,1339,2334,2352,2370}<br />

p resent with node metastases, and this<br />

might account in part for the re l a t i v e l y<br />

favourable overall prognosis of MC.<br />

Table 1.06<br />

Histological criteria required for a diagnosis of MC.<br />

> Syncytial growth pattern (> 75%)<br />

> Absence of glandular structures<br />

> Diffuse lymphoplasmacytic infiltrate,<br />

moderate to marked<br />

> Nuclear pleomorphism, moderate to marked<br />

> Complete histological circumscription<br />

<strong>Invasive</strong> <strong>breast</strong> cancer<br />

29

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!